Home » Topics » Regulatory

Regulatory
RSS

Mylan enters distribution agreement for ranitidine

July 29, 1997

Generic clindamycin approved by FDA

July 28, 1997

Known heart failure drug studied for AML

July 28, 1997

FDA clears potent pain reliever without opioid side effects from Wyeth-Ayerst

July 24, 1997

Teva's generic antihypertensive combination tentatively approved

July 23, 1997

U.K. approves Astra's treatment for ulcerative colitis

July 23, 1997

Prograf to be submitted in Japan for atopic dermatitis

July 22, 1997

TAP receives FDA approval to market new formulation of Lupron Depot

July 21, 1997

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

FDA clears new indication and new labeling for Zoloft

July 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...